Cargando…
PB1942: PARTIAL RESPONSE WITH LYMPHOCYTOSIS (PR-L) IS NOT APPLICABLE FOR ACALABRUTINIB. AN ITALIAN MULTICENTER EXPERIENCE OF REAL LIFE.
Autores principales: | Innocenti, Idanna, Mosca, Antonio, Tomasso, Annamaria, Galitzia, Andrea, Scarfò, Lydia, Galli, Eugenio, Laureana, Roberta, Benintende, Giulia, Mattiello, Veronica, Morelli, Francesca, Chiriu, Sabrina, Del Principe, Maria Ilaria, Zamprogna, Giulia, Gentile, Massimo, Fabbri, Nicole, Autore, Francesco, Sportoletti, Paolo, Fresa, Alberto, Catania, Gioacchino, Coscia, Marta, Tedeschi, Alessandra, Sanna, Alessandro, Varettoni, Marzia, Ghia, Paolo, Murru, Roberta, Laurenti, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430110/ http://dx.doi.org/10.1097/01.HS9.0000974584.83737.e4 |
Ejemplares similares
-
Immune Response to Covid-19 Vaccination in Patients with Chronic Lymphocytic Leukaemia (CLL): An Experience from Two Italian Centres
por: Innocenti, Idanna, et al.
Publicado: (2022) -
PB1933: TREATMENT SEQUENCING AND OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED AT FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS: A THIRTY-YEAR SINGLE-CENTER EXPERIENCE.
por: Fresa, Alberto, et al.
Publicado: (2023) -
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia
por: Frustaci, Anna Maria, et al.
Publicado: (2022) -
VEGF and IL-6 Correlation in POEMS: a Potential Upcoming Marker of Active Disease and Early Autologous BMT Response
por: Tomasso, Annamaria, et al.
Publicado: (2022) -
Measurable residual disease in chronic lymphocytic leukemia
por: Benintende, Giulia, et al.
Publicado: (2023)